2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 23875972 | Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism. | 2013 Aug 22 | 1 |
| 2 | 23899248 | Resistance by allostery: a novel perspective for eg5-targeted drug design. | 2013 Aug 22 | 1 |